Motivational Enhancement System for Adherence (MESA) for Youth Starting ART
Public ClinicalTrials.gov record NCT02761746. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Motivational Enhancement System for Adherence (MESA) for Youth Starting Antiretroviral Therapy (ART)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a multi-site (Detroit, MI; Los Angeles, CA; Philadelphia, PA, Washington, DC; Aurora, CO; Miami, FL; and Baltimore, MD), two-group randomized controlled trial testing a two-session intervention designed to increase motivation for adherence to antiretroviral treatment (ART) among youth living with HIV (YLH) newly recommended to begin medications. Participants are randomized to receive the intervention, Motivational Enhancement System for Adherence (MESA), or the control condition, System for Health (SH: healthy eating and physical activity information). Both groups receive the standard of care regarding the initiation of ART. ART adherence (visual analog scale and hair sample assay) and health outcomes (viral load results, and CD4 counts) are assessed. Additionally, potential mediators (HIV knowledge, motivation for adherence, and self-efficacy for adherence) and predictors of intervention response (substance abuse, mental health symptoms, executive functioning, and stressful life events) are assessed.
Study identification
- NCT ID
- NCT02761746
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 155 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years to 24 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 21, 2016
- Primary completion
- Apr 29, 2021
- Completion
- Apr 29, 2021
- Last update posted
- Aug 18, 2022
2016 – 2021
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital of Los Angeles | Los Angeles | California | 90027 | — |
| University of Colorado School of Medicine | Aurora | Colorado | 80045 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| Univeristy of Miami School of Medicine | Miami | Florida | 33101 | — |
| Johns Hopkins School of Medicine | Baltimore | Maryland | 21287 | — |
| Wayne State University | Detroit | Michigan | 48201 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Medication Adherence trials
Other public records listing Medication Adherence. Sorted by last update posted; newest first. Not a recommendation.
- NCT07742189: Medication Collaboration Feasibility Study Recruiting
- NCT07724652: The AYA Oncology Self-care Movement Not yet recruiting
- NCT05470439: My Interprofessional Care Team for Adherence and Research Engagement Disparities Active, not recruiting
- NCT07223463: A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer Not yet recruiting
- NCT06023615: MITIGAAT: Multifaceted Intervention To Improve Graft Outcome Disparities in African American Kidney Transplants Active, not recruiting
- NCT07599852: MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02761746, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2022 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02761746 live on ClinicalTrials.gov.